[Early detection of exacerbation of lung infections in patients with cystic fibrosis by means of daily spirometry].

G Izbicki, D Trachsel, M Rutishauser, A P Perruchoud, M Tamm
{"title":"[Early detection of exacerbation of lung infections in patients with cystic fibrosis by means of daily spirometry].","authors":"G Izbicki,&nbsp;D Trachsel,&nbsp;M Rutishauser,&nbsp;A P Perruchoud,&nbsp;M Tamm","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Unlabelled: </strong>The clinical course of cystic fibrosis is characterised by pulmonary involvement with mucus retention, chronic pulmonary infection and parenchymal inflammation. Recurrent infectious exacerbations are usually accompanied by a fall in lung volumes. This pilot study investigated whether exacerbations can be detected early by daily spirometry. Ten patients with cystic fibrosis (5 female; 5 male; mean age 24.9 years) performed daily spirometry using a portable transtelephonic spirometer (Spirophone). Infectious exacerbations were diagnosed on clinical grounds and treated without knowledge of the spirometry results. Data of 9 patients recorded over a period of 5-11 months were analysed. One patient was excluded due to non-compliance. A total of 20 infectious exacerbations occurred during the observation period. A fall of at least 20% in one or more of the following parameters was observed in 90% (18/20) of exacerbations: FVC, FEV1, PEF, and FEF25/75. A daily drop in lung volumes of 0.7% to 1.2% was recorded beginning at a median of 33 (20 to 120) days before infectious exacerbations were diagnosed. There was a 2-3% daily improvement in spirometric data under treatment with antibiotics.</p><p><strong>Conclusion: </strong>Daily spirometry allows early recognition of pulmonary infectious exacerbations in patients with cystic fibrosis. Daily spirometry may be used as an indicator for early antibiotic treatment.</p>","PeriodicalId":21484,"journal":{"name":"Schweizerische medizinische Wochenschrift","volume":"130 39","pages":"1361-5"},"PeriodicalIF":0.0000,"publicationDate":"2000-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Schweizerische medizinische Wochenschrift","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Unlabelled: The clinical course of cystic fibrosis is characterised by pulmonary involvement with mucus retention, chronic pulmonary infection and parenchymal inflammation. Recurrent infectious exacerbations are usually accompanied by a fall in lung volumes. This pilot study investigated whether exacerbations can be detected early by daily spirometry. Ten patients with cystic fibrosis (5 female; 5 male; mean age 24.9 years) performed daily spirometry using a portable transtelephonic spirometer (Spirophone). Infectious exacerbations were diagnosed on clinical grounds and treated without knowledge of the spirometry results. Data of 9 patients recorded over a period of 5-11 months were analysed. One patient was excluded due to non-compliance. A total of 20 infectious exacerbations occurred during the observation period. A fall of at least 20% in one or more of the following parameters was observed in 90% (18/20) of exacerbations: FVC, FEV1, PEF, and FEF25/75. A daily drop in lung volumes of 0.7% to 1.2% was recorded beginning at a median of 33 (20 to 120) days before infectious exacerbations were diagnosed. There was a 2-3% daily improvement in spirometric data under treatment with antibiotics.

Conclusion: Daily spirometry allows early recognition of pulmonary infectious exacerbations in patients with cystic fibrosis. Daily spirometry may be used as an indicator for early antibiotic treatment.

[每日肺活量测定法早期发现囊性纤维化患者肺部感染加重]。
未标记:囊性纤维化的临床过程以肺部受累伴黏液潴留、慢性肺部感染和实质炎症为特征。复发性感染加重通常伴有肺容量下降。这项初步研究调查了是否可以通过每日肺活量测定早期发现急性加重。囊性纤维化10例(女5例;5男;平均年龄24.9岁)每日使用便携式经肺活量计(Spirophone)进行肺活量测定。在不知道肺量测定结果的情况下,根据临床诊断和治疗感染加重。对9例患者5 ~ 11个月的资料进行分析。1例患者因不符合而被排除。观察期内共发生20例感染加重。在90%(18/20)的急性加重中,观察到以下一个或多个参数下降至少20%:FVC、FEV1、PEF和FEF25/75。在诊断出感染加重前的中位数33天(20至120天)开始记录到肺容量每日下降0.7%至1.2%。在抗生素治疗下,肺活量测量数据每日改善2-3%。结论:每日肺活量测定可早期识别囊性纤维化患者肺部感染加重。每日肺活量测定可作为早期抗生素治疗的指标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信